awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39440767-6E6EBED3-ABFF-41A5-AF68-A49F805CCED9
Q39440767-6E6EBED3-ABFF-41A5-AF68-A49F805CCED9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39440767-6E6EBED3-ABFF-41A5-AF68-A49F805CCED9
Practical Considerations for the Use of Subcutaneous Treatment in the Management of Dyslipidaemia.
P2860
Q39440767-6E6EBED3-ABFF-41A5-AF68-A49F805CCED9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39440767-6E6EBED3-ABFF-41A5-AF68-A49F805CCED9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
821bdf43c3929d5b8ff47407ed1843e271490f0e
P2860
Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment.